Business Description
TaiMed Biologics Inc
ISIN : TW0004147004
Total Employee Number:
23Description
TaiMed Biologics Inc is a biotechnology company engaged in developing, manufacturing, and commercializing new drugs for the treatment and prevention of infectious diseases. Its products include Trogarzo IV Infusion, Trogarzo IV Push, TMB-365, TMB-365/TMB-380 combination, and Antibody-Drug Conjugates (ADCs). The Group operates in the Americas, which generates maximum revenue, as well as Europe and Taiwan.
Financial Strength
6/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Cash-To-Debt | 3.59 | |||||
Equity-to-Asset | 0.8 | |||||
Debt-to-Equity | 0.13 | |||||
Debt-to-EBITDA | -142.77 | |||||
Piotroski F-Score | 5/9 | |||||
Altman Z-Score | 12.33 | |||||
Beneish M-Score | -3.1 | |||||
WACC vs ROIC | ||||||
Growth Rank
4/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | 0.6 | |||||
3-Year EBITDA Growth Rate | 68.1 | |||||
3-Year EPS without NRI Growth Rate | 16.7 | |||||
3-Year Book Growth Rate | 10 |
Momentum Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
5-Day RSI | 59.48 | |||||
9-Day RSI | 64.9 | |||||
14-Day RSI | 65.47 | |||||
3-1 Month Momentum % | 4.73 | |||||
6-1 Month Momentum % | -6.19 | |||||
12-1 Month Momentum % | -32.71 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Current Ratio | 13.11 | |||||
Quick Ratio | 9.84 | |||||
Cash Ratio | 6.98 | |||||
Days Inventory | 930.75 | |||||
Days Sales Outstanding | 42.03 | |||||
Days Payable | 19.79 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -2.2 | |||||
Shareholder Yield % | 0.37 |
Profitability Rank
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Gross Margin % | 42.44 | |||||
Operating Margin % | -31.84 | |||||
Net Margin % | -27.44 | |||||
EBITDA Margin % | -0.57 | |||||
FCF Margin % | 27.54 | |||||
OCF Margin % | 31.27 | |||||
ROE % | -4.25 | |||||
ROA % | -3.44 | |||||
ROIC % | -6.19 | |||||
3-Year ROIIC % | 0.57 | |||||
ROC (Joel Greenblatt) % | -6.85 | |||||
ROCE % | -3.34 |
GF Value Rank
8/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Forward PE Ratio | 21.63 | |||||
Price-to-Owner-Earnings | 220.13 | |||||
PS Ratio | 31.16 | |||||
PB Ratio | 4.93 | |||||
Price-to-Tangible-Book | 5.56 | |||||
Price-to-Free-Cash-Flow | 114.49 | |||||
Price-to-Operating-Cash-Flow | 100.73 | |||||
EV-to-EBIT | -111.65 | |||||
EV-to-Forward-EBIT | 65.73 | |||||
EV-to-EBITDA | -5077.07 | |||||
EV-to-Forward-EBITDA | 44.41 | |||||
EV-to-Revenue | 28.68 | |||||
EV-to-Forward-Revenue | 18.57 | |||||
EV-to-FCF | 104.95 | |||||
Price-to-GF-Value | 0.81 | |||||
Price-to-Median-PS-Value | 0.74 | |||||
| Price-to-Net-Current-Asset-Value | 8.02 | |||||
| Price-to-Net-Cash | 23.24 | |||||
Earnings Yield (Greenblatt) % | -0.89 | |||||
FCF Yield % | 0.9 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
TaiMed Biologics Inc Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil NT$) | 611.35 | ||
| EPS (TTM) (NT$) | -0.61 | ||
| Beta | 0.0434 | ||
| 3-Year Sharpe Ratio | -0.28 | ||
| 3-Year Sortino Ratio | -0.45 | ||
| Volatility % | 39.36 | ||
| 14-Day RSI | 65.47 | ||
| 14-Day ATR (NT$) | 3.479908 | ||
| 20-Day SMA (NT$) | 63.715 | ||
| 12-1 Month Momentum % | -32.71 | ||
| 52-Week Range (NT$) | 47 - 88.9 | ||
| Shares Outstanding (Mil) | 270.7 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 5 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
TaiMed Biologics Inc Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
TaiMed Biologics Inc Stock Events
| Event | Date | Price (NT$) | ||
|---|---|---|---|---|
| No Event Data | ||||
TaiMed Biologics Inc Frequently Asked Questions
What is TaiMed Biologics Inc(ROCO:4147)'s stock price today?
The current price of ROCO:4147 is NT$69.50. The 52 week high of ROCO:4147 is NT$88.90 and 52 week low is NT$47.00.
When is next earnings date of TaiMed Biologics Inc(ROCO:4147)?
The next earnings date of TaiMed Biologics Inc(ROCO:4147) is .
Does TaiMed Biologics Inc(ROCO:4147) pay dividends? If so, how much?
TaiMed Biologics Inc(ROCO:4147) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Articles on TaiMed Biologics Inc
No articles.
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers